This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Antonio M. Gotto, Jr, MD; John P. Foreyt, PhD; G. Ken Goodrick, PhD

Arch Intern Med. 1982;142(4):682-683.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Bistrian¹ has called attention to the continuing increase in degree of obesity in the United States for more than 100 years. Obesity is known to exacerbate risk factor abnormalities for cardiovascular disease, namely, hypertension, diabetes, and hyperlipidemia. Obesity per se becomes a risk factor for increased mortality at body weights greater than 130% of ideal.² Brownell and Stunkard³ have recently observed a favorable effect of weight reduction on plasma lipoprotein levels in obese subjects.

Over the last decade, there has been a proliferation of commercial weight-reduction clinics to serve this expanding market. These clinics have brought the promise of relatively inexpensive treatment for the masses; 1 million people in the United States participate in group weightloss programs each week.⁴ However, physicians⁵ and behavioral scientists^6,7 have failed to develop a treatment regimen that is effective and long-lasting for the majority of those treated. Since one . . . [Full Text PDF of this Article]

Author Affiliations
Department of Medicine Baylor College of Medicine— The Methodist Hospital Houston, TX 77030; Department of Psychology University of Houston Houston, TX 77030

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?